Drug Shortage Report for INQOVI

Last updated on 2022-05-23 History
Report ID 152829
Drug Identification Number 02501600
Brand name INQOVI
Common or Proper name cedazuridine and decitabine
Company Name OTSUKA PHARMACEUTICAL CO LTD
Market Status MARKETED
Active Ingredient(s)
Strength(s) 100MG 35MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size blister
ATC code L01BC
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-03-15
Actual start date
Estimated end date 2022-05-20
Actual end date 2022-05-20
Shortage status Resolved
Updated date 2022-05-23
Company comments Manufacturing delay
Health Canada comments
Tier 3 Status Yes
Contact Address 2-9 KANDA-TSUKASAMACHI
CHIYODA-KU TOKYO, --
JAPAN 101-8535
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-05-23 French Compare
v10 2022-05-23 English Compare
v9 2022-05-09 French Compare
v8 2022-05-09 English Compare
v7 2022-03-16 English Compare
v6 2022-01-27 English Compare
v5 2022-01-14 French Compare
v4 2022-01-14 English Compare
v3 2022-01-14 French Compare
v2 2022-01-14 English Compare
v1 2022-01-14 English Compare

Showing 1 to 11 of 11